# FDA recall D-0299-2021

> **Ferring Pharmaceuticals Inc** · Class III · drug recall initiated 2021-03-02.

## Product

Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials of Menotropins for injection, 5 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-2; b) Professional Sample Kit: 3 single dose vials of Menotropins for injection, 3 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-3; Rx Only, Manufactured for Ferring Pharmaceuticals Inc. Parsippany. NJ 07054. Diluent manufactured for Ferring Pharmaceuticals Inc.

## Reason for recall

Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP

## Distribution

Distributed nationwide in the USA.

## Key facts

- **Recall number:** D-0299-2021
- **Recalling firm:** Ferring Pharmaceuticals Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-03-02
- **Report date:** 2021-03-17
- **Termination date:** 2022-03-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0299-2021

## Citation

> AI Analytics. FDA recall D-0299-2021. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0299-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
